Cargando…

Temporomandibular disorders in patients with schizophrenia using antipsychotic agents: a discussion paper

Patients with psychiatric problems show a tendency to develop temporomandibular disorders (TMD). Particularly, patients with schizophrenia are quite likely to have signs and symptoms of TMD due to the impairment of their oral health, the use of antipsychotic drugs, and other general health problems....

Descripción completa

Detalles Bibliográficos
Autores principales:	de Araújo, Arão Nogueira, do Nascimento, Marion Alves, de Sena, Eduardo Pondé, Baptista, Abrahão Fontes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956479/ https://www.ncbi.nlm.nih.gov/pubmed/24648768 http://dx.doi.org/10.2147/DHPS.S57172

Ejemplares similares

Antipsychotic agents: efficacy and safety in schizophrenia
por: de Araújo, Arão Nogueira, et al.
Publicado: (2012)

Use of transcranial direct current stimulation for the treatment of auditory hallucinations of schizophrenia – a systematic review
por: Pondé, Pedro H, et al.
Publicado: (2017)

A Randomized, Double-Blind, Sham-Controlled Trial of Transcranial Direct Current Stimulation in Attention-Deficit/Hyperactivity Disorder
por: Cosmo, Camila, et al.
Publicado: (2015)

Contribution of Transcranial Direct Current Stimulation on Inhibitory Control to Assess the Neurobiological Aspects of Attention Deficit Hyperactivity Disorder: Randomized Controlled Trial
por: Cosmo, Camila, et al.
Publicado: (2015)

Analgesic effect of cathodal transcranial current stimulation over right dorsolateral prefrontal cortex in subjects with muscular temporomandibular disorders: study protocol for a randomized controlled trial
por: Brandão Filho, Rivail Almeida, et al.
Publicado: (2015)

Safety and tolerability of antipsychotics: focus on amisulpride
por: Juruena, Mario F, et al.
Publicado: (2010)

Spreading Effect of tDCS in Individuals with Attention-Deficit/Hyperactivity Disorder as Shown by Functional Cortical Networks: A Randomized, Double-Blind, Sham-Controlled Trial
por: Cosmo, Camila, et al.
Publicado: (2015)

Sertindole in the Management of Schizophrenia
por: Juruena, Mario F., et al.
Publicado: (2011)

Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
por: Ren, Xinhua S, et al.
Publicado: (2009)

Influence of Antipsychotic Agents on the Sexuality of Patients Diagnosed with Schizophrenia
por: Fares, Jaballah, et al.
Publicado: (2023)

The Papers and Discussions
Publicado: (1911)

Augmentation of Antipsychotic Medications with Low-Dose Clozapine in Treatment-Resistant Schizophrenia—Case Reports and Discussion
por: Harrison, Zoe, et al.
Publicado: (2021)

Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression
por: Loebel, Antony, et al.
Publicado: (2015)

Discussion of Tanaka's paper.
por: Hayashi, C
Publicado: (1979)

BILATERAL TEMPOROMANDIBULAR JOINT DISLOCATION AND ANTIPSYCHOTIC TREATMENT: A CASE REPORT
por: Obrador i Font, R., et al.
Publicado: (2023)

Antipsychotic medication for women with schizophrenia spectrum disorders
por: Brand, Bodyl A., et al.
Publicado: (2022)

Pain prevalence, characteristics and associated factors in human T-cell lymphotropic virus type 1 infected patients: a systematic review of the literature
por: San-Martin, Daniel Lordelo, et al.
Publicado: (2016)

Discussion on the Pension Fund Paper
Publicado: (1887)

Discussion of Papers on Filling Materials
Publicado: (1905)

Discussion of Dr. Clarke’s Paper
por: Boynton, C. E.
Publicado: (1907)

Discussion of Dr. Taylor’s Paper
Publicado: (1907)

Discussion of Dr. Tignor’s Paper
Publicado: (1907)

Discussion of Dr. Toepel’s Paper
Publicado: (1907)

Discussion of Dr. Goldsmith’s Paper
por: Smith, Marvin H.
Publicado: (1907)

Discussion of Dr. Jones’ Paper
Publicado: (1907)

Discussion on Prof. Keiller’s Paper
Publicado: (1892)

Discussion on Dr. Wallace’s Paper
Publicado: (1895)

Discussion on Dr. Cunningham’s Paper
por: Christian, G. W.
Publicado: (1894)

Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia
por: Potkin, Steven, et al.
Publicado: (2013)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Language disturbances in schizophrenia: the relation with antipsychotic medication
por: de Boer, J. N., et al.
Publicado: (2020)

Antipsychotic medication for women with schizophrenia spectrum disorders – CORRIGENDUM
por: Brand, Bodyl A., et al.
Publicado: (2023)

Cost of antipsychotic polypharmacy in the treatment of schizophrenia
por: Zhu, Baojin, et al.
Publicado: (2008)

Comparative effectiveness of antipsychotic drugs in schizophrenia
por: Stroup, T. Scott, et al.
Publicado: (2000)

The heterogeneity of antipsychotic response in the treatment of schizophrenia
por: Case, M., et al.
Publicado: (2011)

New atypical antipsychotics for schizophrenia: iloperidone
por: Caccia, Silvio, et al.
Publicado: (2010)

Osteoporosis Associated with Antipsychotic Treatment in Schizophrenia
por: Wu, Haishan, et al.
Publicado: (2013)

Polypharmacy Management of Antipsychotics in Patients with Schizophrenia
por: Kamei, Hiroyuki
Publicado: (2022)

Discussion on Mr. Nelson Hardy's Paper
Publicado: (1889)

Address by President Betty: Paper and Discussion
Publicado: (1892)

Cannot write session to /tmp/vufind_sessions/sess_4t4a3ro8p309ffp810d56sl5vu